US Patent 10842882 Amatoxin-antibody conjugates
Patent 10842882 was granted and assigned to Heidelberg Pharma on November, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 7, 2016
Date of Patent
November 24, 2020
Patent Applicant
Patent Application Number
15556830
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10842882 Amatoxin-antibody conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.